Tag Archives: Takeda Pharmaceuticals

The Lack of New Diabetes Drugs Makes Glucose Management Even More Important

canstockphoto13218168

Recently, Bristol-Myers Squibb announced that it was getting out of the diabetes drug business. Following that announcement, Takeda Pharmaceuticals – which had high hopes of launching their new diabetes drug Fasiglifam – had to drop it because of liver toxicity problems. Precious few new diabetes drugs appear to be in the pipeline because the FDA… read more